NeoPeptide Innovations Limited
芯肽生物科技有限公司
Incorporated 3 years ago
Data updated: 2026-03-25
About this company
NeoPeptide Innovations Limited is a Hong Kong private company limited by shares incorporated on September 27, 2023. It is registered with company registration (CR) number 3322860 and business registration number (BRN) 75757947. The company is currently active on the Hong Kong Companies Register. Its registered office is at UNIT 811, BEVERLEY COMMERCIAL CENTRE, 87-105 CHATHAM ROAD SOUTH, TSIM SHA TSUI, KOWLOON, HONG KONG. The most recent filing with the Companies Registry on record is (E)FNAR1 - Annual Return on October 20, 2025.
Company Information
- CR Number
- 3322860
- BRN
- 75757947
- Company Type
- Private Limited by Shares
- Type Category
- Local Company
Dates & Status
- Incorporation Date
- 2023-09-27
- Dissolution Date
- -
- Has Charges
- No
- Dormant
- No
- Registered Address
- UNIT 811, BEVERLEY COMMERCIAL CENTRE, 87-105 CHATHAM ROAD SOUTH, TSIM SHA TSUI, KOWLOON, HONG KONG
Name History
| Name | From | To |
|---|---|---|
| NeoPeptide Innovations Limited | 2023-09-27 | Current |
| 芯肽生物科技有限公司 | 2023-09-27 | Current |
Need this data via API? Get full access at Renavon.com →
Company Documents
Order any single document below| Document | Filing Date | Buy |
|---|---|---|
| (E)FNAR1 - Annual Return | 2025-10-20 | |
| (E)FND2B - Notice of Change in Particulars of Company Secretary and Director | 2025-10-17 | |
| (E)FNR1 - Notice of Change of Address of Registered Office | 2025-10-17 | |
| (E)FNAR1 - Annual Return | 2024-09-30 | |
| (E)FND4 - Notice of Resignation of Company Secretary and Director | 2024-07-29 | |
| (E)FND2A - Notice of Change of Company Secretary and Director (Appointment/Cessation) | 2024-07-29 | |
| Information Sheet regarding Using Business Registration Number as Unique Business Identifier | 2023-12-27 | |
| Certificate of Incorporation | 2023-09-27 | |
| (E)FNNC1 - Incorporation Form (Company Limited by Shares) | 2023-09-27 | |
| (E)Articles of Association | 2023-09-27 |
Confirm order
NeoPeptide Innovations Limited